Effect of iron dose in maternal multiple micronutrient supplement on perceived side effects, adherence, acceptability and preferences: protocol for a randomised crossover trial

Christopher R Sudfeld, Alfa Muhihi, Allison C Sylvetsky, Emmy Metta, Victoria S Brownlee, Erin M Oakley, Mohamed Bakari, Wafaie W Fawzi, Shabani Kinyogoli, Jordan R Kuiper, Sabina Mugusi, Qing Pan, Mary M Sando, Blair J Wylie, Honorati Masanja, Emily R Smith, Andrea B Pembe · 2026

Read Effect of iron dose in maternal multiple micronutrient supplement on perceived side effects, adherence, acceptability and preferences: protocol for a randomised crossover trial by Christopher R Sudfeld, Alfa Muhihi, Allison C Sylvetsky, Emmy Metta, Victoria S Brownlee, Erin M Oakley, Mohamed Bakari, Wafaie W Fawzi, Shabani Kinyogoli, Jordan R Kuiper, Sabina Mugusi, Qing Pan, Mary M Sando, Blair J Wylie, Honorati Masanja, Emily R Smith, Andrea B Pembe (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13218192.txt.

Description

Christopher R. Sudfeld and colleagues outline a 2026 protocol for a crossover trial testing how the iron dose in pregnancy supplements affects the women who take them. Iron supplements prevent anaemia but can cause side effects that discourage daily use, and programs are weighing a switch from iron-folic acid tablets to micronutrient supplements with less iron. Whether a lower dose feels more acceptable, without losing the benefit, is an open question.

In Dar es Salaam, Tanzania, 156 pregnant women will take three supplement formulations in a randomized order, containing 60, 45, and 30 milligrams of elemental iron, one month at a time. The trial is quadruple-blind, so neither participants nor analysts know the sequence. Acceptability on a rating scale is the main outcome, alongside women's most and least preferred formulation, reported side effects, and adherence counted from returned pills. Interviews with a subsample will explore how the formulations felt in daily life.

Catalog record

CREATORChristopher R Sudfeld, Alfa Muhihi, Allison C Sylvetsky, Emmy Metta, Victoria S Brownlee, Erin M Oakley, Mohamed Bakari, Wafaie W Fawzi, Shabani Kinyogoli, Jordan R Kuiper, Sabina Mugusi, Qing Pan, Mary M Sando, Blair J Wylie, Honorati Masanja, Emily R Smith, Andrea B Pembe
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13218192

Browse the full library · About the Tower of Babel